1. Stocks
  2. Vivos Therapeutics Inc
  3. Swot
swot-logo

Vivos Therapeutics Inc SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Vivos Therapeutics Inc has 19 Strengths, 6 Weaknesses, 4 Opportunities and 0 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

30 Day SMA crossing over 200 Day SMA, and current price greater than open

Strong Momentum: Price above short, medium and long term moving averages

Relative Outperformance versus Industry over 1 Month

Rising Net Cash Flow and Cash from Operating activity

Relative Outperformance versus Industry over the Quarter (3 Months)

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Month

Companies with Low Debt

Companies with reducing Debt

Company able to generate Net Cash - Improving Net Cash Flow for last 2 years

Stock gained more than 20% in one month

Annual Net Profits improving for last 2 years

Top Gainers

Stock with Low PE (PE < = 10)

RSI indicating price strength

Highest Recovery from 52 Week Low

Stocks Outperforming their Industry Price Change in the Quarter

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Degrowth in Quarterly Revenue and Profit in Recent Results(YoY)

Low Piotroski Score : Companies with weak financials

Recent Results: Declining Operating Profit Margin and Net Profits (YoY)

Declining profits every quarter for the past 3 quarters

Declining Revenue every quarter for the past 3 quarters

Mutual Funds Increased Shareholding in Past Month

Mutual Funds Increased Shareholding over the Past Two Months

MFs increased their shareholding last quarter

Mf buying for 2 months

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks